{"id":"https://openalex.org/W2536079445","doi":"https://doi.org/10.1158/1535-7163.mct-16-0449","title":"Preclinical Efficacy of an Antibody\u2013Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET","display_name":"Preclinical Efficacy of an Antibody\u2013Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET","publication_year":2016,"publication_date":"2016-10-19","ids":{"openalex":"https://openalex.org/W2536079445","doi":"https://doi.org/10.1158/1535-7163.mct-16-0449","mag":"2536079445","pmid":"https://pubmed.ncbi.nlm.nih.gov/27760836"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-16-0449","doi":"https://doi.org/10.1158/1535-7163.mct-16-0449","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0449","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110338952","display_name":"Anton G.T. Terwisscha van Scheltinga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Anton G.T. Terwisscha van Scheltinga","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","2Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands","1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California.; 2Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"2Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]},{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California.; 2Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009121714","display_name":"Annie K. Ogasawara","orcid":"https://orcid.org/0009-0000-5191-9357","observed_orcids":["https://orcid.org/0009-0000-5191-9357"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annie Ogasawara","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066917304","display_name":"Glenn Pacheco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn Pacheco","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065902394","display_name":"Alexander N. Vanderbilt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander N. Vanderbilt","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011569673","display_name":"Jeff N. Tinianow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff N. Tinianow","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073575743","display_name":"Nidhi Gupta","orcid":"https://orcid.org/0000-0003-2565-2446","observed_orcids":["https://orcid.org/0000-0003-2565-2446"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nidhi Gupta","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100384469","display_name":"Dongwei Li","orcid":"https://orcid.org/0009-0003-0945-7357","observed_orcids":["https://orcid.org/0009-0003-0945-7357","https://orcid.org/0000-0001-8914-3021"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dongwei Li","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005525867","display_name":"Ron Firestein","orcid":"https://orcid.org/0000-0002-5255-1838","observed_orcids":["https://orcid.org/0000-0002-5255-1838"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ron Firestein","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074581811","display_name":"Jan Ma\u0159\u0131\u0301k","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan Marik","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086884574","display_name":"Suzie J. Scales","orcid":"https://orcid.org/0000-0003-2544-0283","observed_orcids":["https://orcid.org/0000-0003-2544-0283"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzie J. Scales","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108381313","display_name":"Simon\u2010Peter Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simon-Peter Williams","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech, Inc,. South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0808,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.86125782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"1","first_page":"134","last_page":"142"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5619999766349792},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6800000071525574},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.6570000052452087},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4819999933242798},{"id":"https://openalex.org/keywords/predictive-imaging","display_name":"predictive imaging","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.9882994890213013},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.7934675216674805},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7427802681922913},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6425783634185791},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5506144165992737},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5312509536743164},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5049801468849182},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.49769213795661926},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47048428654670715},{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.4258575141429901},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41827940940856934},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36163991689682007},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20272082090377808},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1967163383960724},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18718838691711426},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1615070402622223},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000090204","descriptor_name":"Mesothelin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015040","descriptor_name":"Zirconium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-16-0449","doi":"https://doi.org/10.1158/1535-7163.mct-16-0449","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0449","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:27760836","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27760836","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/40c2a5a4-e9b4-4f58-b66e-dd46f664effd","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/40c2a5a4-e9b4-4f58-b66e-dd46f664effd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terwisscha Van Scheltinga, A, Ogasawara, A, Pacheco, G, Vanderbilt, A N, Tinianow, J N, Gupta, N, Li, D, Firestein, R, Marik, J, Scales, S J & Williams, S-P 2017, 'Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative Zr-89-ImmunoPET', Molecular cancer therapeutics, vol. 16, no. 1, pp. 134-142. https://doi.org/10.1158/1535-7163.MCT-16-0449","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/40c2a5a4-e9b4-4f58-b66e-dd46f664effd","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/40c2a5a4-e9b4-4f58-b66e-dd46f664effd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular cancer therapeutics, 16(1), 134 - 142. AMER ASSOC CANCER RESEARCH","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312568","display_name":"Public Health Agency of Canada","ror":"https://ror.org/023xf2a37"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1503438909","https://openalex.org/W1871670984","https://openalex.org/W1921438311","https://openalex.org/W1963880417","https://openalex.org/W1977703188","https://openalex.org/W1994570353","https://openalex.org/W2026373761","https://openalex.org/W2030600067","https://openalex.org/W2041545883","https://openalex.org/W2043995727","https://openalex.org/W2082115360","https://openalex.org/W2087785208","https://openalex.org/W2090057677","https://openalex.org/W2090294646","https://openalex.org/W2101338245","https://openalex.org/W2115269770","https://openalex.org/W2122767481","https://openalex.org/W2124514746","https://openalex.org/W2128903029","https://openalex.org/W2130870133","https://openalex.org/W2138654358","https://openalex.org/W2140317464","https://openalex.org/W2147157147","https://openalex.org/W2151021631","https://openalex.org/W2159967578","https://openalex.org/W2160574552","https://openalex.org/W2168077975","https://openalex.org/W2172175430","https://openalex.org/W2179836657","https://openalex.org/W2199851823","https://openalex.org/W2214547644","https://openalex.org/W2286884046"],"related_works":["https://openalex.org/W1921438311","https://openalex.org/W2321300006","https://openalex.org/W2199851823","https://openalex.org/W7073846565","https://openalex.org/W1993863777","https://openalex.org/W2899390133","https://openalex.org/W3090682239","https://openalex.org/W2332192134","https://openalex.org/W2082115360","https://openalex.org/W2138654358"],"abstract_inverted_index":{"Abstract":[0],"Antibody\u2013drug":[1],"conjugates":[2],"(ADC)":[3],"use":[4],"monoclonal":[5],"antibodies":[6],"(mAb)":[7],"as":[8,54,61],"vehicles":[9],"to":[10,16,48,172],"deliver":[11],"potent":[12],"cytotoxic":[13,174],"drugs":[14],"selectively":[15],"tumor":[17,59,68,124],"cells":[18],"expressing":[19],"the":[20,36,111,148,164,173],"target.":[21],"Molecular":[22],"imaging":[23],"with":[24,163],"zirconium-89":[25],"(89Zr)-labeled":[26],"mAbs":[27],"recapitulates":[28],"similar":[29],"targeting":[30],"biology":[31],"and":[32,57,94,118,134,152,160],"might":[33],"help":[34],"predict":[35],"efficacy":[37,53,165],"of":[38,85,102,126,154,166],"these":[39],"ADCs.":[40],"An":[41],"anti-mesothelin":[42],"antibody":[43,157],"(AMA,":[44],"MMOT0530A)":[45],"was":[46,79,105],"used":[47],"make":[49],"comparisons":[50],"between":[51],"its":[52,58],"an":[55,155],"ADC":[56,76,156,168],"uptake":[60,125,140],"measured":[62,80],"by":[63,71],"89Zr":[64],"immunoPET":[65],"imaging.":[66],"Mesothelin-targeted":[67],"growth":[69,113],"inhibition":[70,114],"monomethyl":[72],"auristatin":[73],"E":[74],"(MMAE),":[75],"AMA-MMAE":[77,109],"(DMOT4039A),":[78],"in":[81,115,158,169],"mice":[82],"bearing":[83],"xenografts":[84,131],"ovarian":[86],"cancer":[87],"OVCAR-3\u00d72.1,":[88,116],"pancreatic":[89],"cancers":[90],"Capan-2,":[91,117],"HPAC,":[92],"AsPC-1,":[93],"HPAF-II,":[95,133],"or":[96],"mesothelioma":[97],"MSTO-211H.":[98],"Ex":[99],"vivo":[100,159],"analysis":[101],"mesothelin":[103,143],"expression":[104],"performed":[106],"using":[107],"immunohistochemistry.":[108],"showed":[110,122],"greatest":[112],"HPAC":[119],"tumors,":[120],"which":[121],"target-specific":[123],"89Zr-AMA.":[127],"The":[128],"less":[129],"responsive":[130],"(AsPC-1,":[132],"MSTO-211H)":[135],"did":[136],"not":[137],"show":[138],"89Zr-AMA":[139],"despite":[141],"confirmed":[142],"expression.":[144],"ImmunoPET":[145],"can":[146],"demonstrate":[147],"necessary":[149],"delivery,":[150],"binding,":[151],"internalization":[153],"this":[161],"correlates":[162],"mesothelin-targeted":[167],"tumors":[170],"vulnerable":[171],"drug":[175],"delivered.":[176],"Mol":[177],"Cancer":[178],"Ther;":[179],"16(1);":[180],"134\u201342.":[181],"\u00a92016":[182],"AACR.":[183]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-10-28T00:00:00"}